Chronic myeloid leukemia (CML) is a clonal myeloproliferative expansion of transformed,
primitive hematopoietic progenitor cells. It involves myeloid, monocytic, erythroid, …

Chronic myeloid leukemia (CML) is probably the most extensively studied human malignancy.
The discovery of the Philadelphia (Ph) chromosome in 19601 as the first consistent …

… ‐apoptosis, metabolism and stemness, has made the study of chronic myeloid leukemia
the most successful field in tumor biology. However, we now face the issue of drug resistance …

Chronic myelogenous leukemia (CML) is a malignant disease of the human hematopoietic
stem cell. The disease is characterized by an abnormal expansion of granulocytic progenitors …

… breakpoint in chronic myeloid leukemia with poor outcome. Leukemia. 2003; 17: 1313-1323 …
(e6a2) in a patient with Philadelphia chromosome negative chronic myelogenous leukemia. …

… In the past decade clinical and laboratory studies have led to important new insights into
the biology of chronic myeloid leukemia (CML). Basic science has defined the molecular …

Over the past decades the prognosis of patients with Chronic Myeloid Leukemia (CML) has
radically changed due to groundbreaking scientific and translational studies that have …

… promise for the cure of chronic myelogenous leukemia. Chronic myelogenous leukemia is
a … the clinically relevant biology and treatment advances in chronic myelogenous leukemia. …

… In this report, we discuss the biological basis for such translation and highlight the current
and potential tools for the effective treatment of CML patients. The first part presents a review of …

… Center long-term experience of chronic myeloid leukemia … Induction of chronic myelogenous
leukemia in mice by the … The molecular biology of chronic myeloid leukemia. Blood 96…